Last reviewed · How we verify

NCT04458077

Discover Learning - Social, Emotional and Identity Learning for Very Young Adolescents

Completed NA Last updated 4 November 2021
What this trial tests

NA trial testing Discover Learning (SEIL) in Behavior, Adaptive in 333 participants. Completed in 30 April 2021.

Timeline
30 August 2020
Primary endpoint
12 December 2020
30 April 2021

Quick facts

Lead sponsorUniversity of California, Berkeley
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment333
Start date30 August 2020
Primary completion12 December 2020
Estimated completion30 April 2021
Sites4 locations across Tanzania

Drugs / interventions tested

Conditions studied

Sponsor

University of California, Berkeley

Who can join

Adults 9 to 14, any sex, with Behavior, Adaptive or Behavior, Child. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary aim of the Discover Learning Project (Discover) is to test an intervention for Very Young Adolescents (VYAs) to promote positive, gender norm transformative, social emotional and identity learning (SEIL). A secondary aim is to better identify effective components of Discover that are scalable requiring the lowest resources to implement

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. An Intervention to Enhance Social, Emotional, and Identity Learning for Very Young Adolescents and Support Gender Equity: Protocol for a Pragmatic Randomized Controlled Trial.
    Cherewick M, Lebu S, Su C, Dahl RE. · · 2020 · cited 8× · PMID 33206624 · DOI 10.2196/23071

Verify or expand the search:

Other University of California, Berkeley trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04458077.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing